ICAN has procured exclusive lot and dose data for the Johnson & Johnson (Janssen) COVID-19 vaccine. As with the Pfizer and Moderna lot and dose data obtained by ICAN, this data may help make it possible to determine if certain lots were associated with unusually high numbers of adverse reactions or deaths. An analysis of this data has been conducted by OpenVAERS.
ICAN recently broke the news that its legal team had wrangled detailed lot and dose data for the Pfizer and Moderna mRNA vaccines from CDC. Now, ICAN is happy to announce that we have likewise also obtained the critical lot and dose data for the Johnson & Johnson (J&J) vaccine.
ICAN has again shared this data with OpenVAERS which has added the J&J data to its COVID-19 Vaccine Lots page. OpenVAERS has conducted its own assessment of the lot data and, according to that assessment, as with the Pfizer and Moderna vaccines, the most dangerous lots appear to be among the first shipped.
This data is a culmination of a two-and-a-half-year legal battle. While CDC begrudgingly released some lot data previously, ICAN’s legal team persisted and was ultimately able to obtain the most complete dataset yet, which includes previously unreleased lot and dose data. Now, this information may finally permit members of the public to determine if the dose they or a loved one received was part of a potential “hot lot.”
Of course, when numerous lots come back “hot” it could just mean you have a “hot” product. Hence this data could also assist in showing that it was not any particular lot that was hot, but rather the COVID-19 vaccine products themselves that were “hot”!
You can download the J&J data here, the Moderna data here, and the Pfizer data here. Check out OpenVAERS’ analysis of the data here, here, and here. As always, ICAN encourages everyone to pull the raw data and conduct their own analyses.
See the links below for some of ICAN’s additional work on COVID-19 vaccines:
- UPDATE: ICAN OBTAINS ADDITIONAL AND MORE COMPLETE PFIZER VACCINE LOT, DOSE, AND DISTRIBUTION DATA
- EXCLUSIVE: ICAN OBTAINS CRUCIAL PFIZER VACCINE LOT, DOSE, AND DISTRIBUTION INFORMATION
- FDA ADMITS IT HAS NO RECORDS INDICATING COVID-19 VACCINE SAFETY PROTOCOLS WERE FOLLOWED
- ICAN DEMANDS ANSWERS ABOUT DEATH DISCREPANCIES IN PFIZER’S CLINICAL TRIAL
- CDC ADMITS ONCE AND FOR ALL IT HAS NO BASIS FOR ITS CLAIM THAT COVID-19 VACCINES DO NOT CAUSE VARIANTS
- THE CDC’S RESPONSE TO SCIENTIFIC INQUIRY: BECAUSE WE SAID SO!
